NPI: 1578530986 · MIAMI, FL 33155 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/03/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/03/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,337 | $1.50M |
| 2019 | 26,954 | $2.70M |
| 2020 | 28,617 | $3.30M |
| 2021 | 19,601 | $461K |
| 2022 | 14,171 | $464K |
| 2023 | 5,910 | $112K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 38,691 | 1,743 | $3.08M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 34,979 | 1,402 | $2.17M |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,183 | 881 | $1.30M |
| A4657 | Syringe, with or without needle, each | 4,037 | 1,451 | $646K |
| J1756 | Injection, iron sucrose, 1 mg | 4,995 | 838 | $413K |
| 85041 | 2,264 | 1,280 | $151K | |
| 85048 | 2,275 | 1,283 | $151K | |
| 83970 | 1,846 | 976 | $147K | |
| 83540 | 2,012 | 1,178 | $145K | |
| 83550 | 1,966 | 1,156 | $140K | |
| 82728 | 1,280 | 741 | $103K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 625 | 279 | $52K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 196 | 93 | $9K |
| 90662 | 51 | 39 | $9K | |
| 82108 | 117 | 71 | $8K | |
| G0008 | Administration of influenza virus vaccine | 59 | 40 | $4K |
| 82947 | 14 | 13 | $753.90 |